CAS: 1952272-74-0
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Bemarituzumab REF: TM-T76673CAS: 1952272-74-0 | SDS-PAGE:95% SEC-HPLC:99.99% | 185,00 €~2.219,00 € | Vie 12 Jul 24 | |
Bemarituzumab REF: 3D-CLA1499CAS: 1952272-74-0 | - - - | A consultar | Lun 22 Jul 24 |
Bemarituzumab
CAS:1952272-74-0
Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding …
Pureza:
SDS-PAGE:95% SEC-HPLC:99.99%
Forma y color:
Solid
Ref: TM-T76673
1mg | 185,00 € | ||
5mg | 502,00 € | ||
10mg | 802,00 € | ||
25mg | 1.203,00 € | ||
50mg | 1.633,00 € | ||
100mg | 2.219,00 € |
Entrega estimada en Estados Unidos, el Viernes 12 de Julio de 2024
Bemarituzumab
CAS:1952272-74-0
Humanized, afucosylated IgG1 monoclonal antibody targeting fibroblast growth factor receptor 2b (FGFR2b)
Ref: 3D-CLA1499
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Lunes 22 de Julio de 2024